AACR PATIENT ADVOCATE FORUM
The evolution of FDA regulatory science and its impact on cancer
Tuesday, June 27, 2023
Virtualregister for on demand viewing
This is an important time for regulatory science in cancer research. The increasing number and diversity of medical interventions, data opportunities, and novel clinical trial designs are challenging traditional regulatory processes and spurring the need for significant innovation in regulatory practice. Patient expectations for earlier access to innovations and for involvement in regulatory decision-making add to the opportunities for new methodologies and data sources. This AACR Patient Advocate Forum will explore how regulatory science is evolving to meet the growing complexity of cancer research and optimize regulation to support the prevention, diagnosis, and treatment of cancers.
Anna D. Barker, PhD, FAACR, Ellison Institute for Transformative Medicine
Allison Rosen, MS, Project ECHO, American Cancer Society
Richard Pazdur, MD, FDA Oncology Center of Excellence
David R. Parkinson, MD, ESSA Pharma, Inc.
Kenneth C. Anderson, MD, FAACR, Dana-Farber Cancer InstituteProgram Agenda Speaker Bios
AACR Patient Advocate Forums
The AACR is committed to providing educational programming to patients with cancer and patient advocacy communities to support their collective mission to find cures for all cancers. AACR Patient Advocate Forums invite leaders from patient advocacy, academia, industry, and healthcare communities to discuss pressing topics and the latest discoveries in cancer research. These virtual forums are provided quarterly at no cost to attendees and open to the public.